Analysis of the relationship between Ki-67 expression and chemotherapy and prognosis in advanced non-small cell lung cancer

Abstract

The Ki-67 index might be a clinically significant biomarker in advanced NSCLC and may be able to predict the efficacy of chemotherapy. High expression of Ki-67 might also be an indicator of shortened PFS time.